38872258|t|Arctigenin derivative A-1 ameliorates motor dysfunction and pathological manifestations in SOD1G93A transgenic mice via the AMPK/SIRT1/PGC-1alpha and AMPK/SIRT1/IL-1beta/NF-kappaB pathways.
38872258|a|AIM: Amyotrophic lateral sclerosis (ALS) is a severe neurodegenerative disease characterized by progressive death of upper and lower motor neurons, leading to generalized muscle atrophy, paralysis, and even death. Mitochondrial damage and neuroinflammation play key roles in the pathogenesis of ALS. In the present study, the efficacy of A-1, a derivative of arctigenin with AMP-activated protein kinase (AMPK) and silent information regulator 1 (SIRT1) activation for ALS, was investigated. METHODS: A-1 at 33.3 mg/kg was administrated in SOD1G93A transgenic mice orally from the 13th week for a 6-week treatment period. Motor ability was assessed before terminal anesthesia. Muscle atrophy and fibrosis, motor neurons, astrocytes, and microglia in the spinal cord were evaluated by H&E, Masson, Sirius Red, Nissl, and immunohistochemistry staining. Protein expression was detected with proteomics analysis, Western blotting, and ELISA. Mitochondrial adenosine triphosphate (ATP) and malondialdehyde (MDA) levels were measured using an assay kit. RESULTS: A-1 administration in SOD1G93A mice enhanced mobility, decreased skeletal muscle atrophy and fibrosis, mitigated loss of spinal motor neurons, and reduced glial activation. Additionally, A-1 treatment improved mitochondrial function, evidenced by elevated ATP levels and increased expression of key mitochondrial-related proteins. The A-1 treatment group showed decreased levels of IL-1beta, pIkappaBalpha/IkappaBalpha, and pNF-kappaB/NF-kappaB. CONCLUSIONS: A-1 treatment reduced motor neuron loss, improved gastrocnemius atrophy, and delayed ALS progression through the AMPK/SIRT1/PGC-1alpha pathway, which promotes mitochondrial biogenesis. Furthermore, the AMPK/SIRT1/IL-1beta/NF-kappaB pathway exerted neuroprotective effects by reducing neuroinflammation. These findings suggest A-1 as a promising therapeutic approach for ALS.
38872258	0	25	Arctigenin derivative A-1	Chemical	-
38872258	38	55	motor dysfunction	Disease	MESH:D000068079
38872258	111	115	mice	Species	10090
38872258	129	134	SIRT1	Gene	93759
38872258	135	145	PGC-1alpha	Gene	19017
38872258	155	160	SIRT1	Gene	93759
38872258	161	169	IL-1beta	Gene	16176
38872258	170	179	NF-kappaB	Gene	18033
38872258	195	224	Amyotrophic lateral sclerosis	Disease	MESH:D000690
38872258	226	229	ALS	Disease	MESH:D000690
38872258	243	268	neurodegenerative disease	Disease	MESH:D019636
38872258	298	303	death	Disease	MESH:D003643
38872258	361	375	muscle atrophy	Disease	MESH:D009133
38872258	377	386	paralysis	Disease	MESH:D010243
38872258	397	402	death	Disease	MESH:D003643
38872258	404	424	Mitochondrial damage	Disease	MESH:D028361
38872258	429	446	neuroinflammation	Disease	MESH:D000090862
38872258	485	488	ALS	Disease	MESH:D000690
38872258	549	559	arctigenin	Chemical	MESH:C071942
38872258	605	635	silent information regulator 1	Gene	93759
38872258	637	642	SIRT1	Gene	93759
38872258	659	662	ALS	Disease	MESH:D000690
38872258	750	754	mice	Species	10090
38872258	867	881	Muscle atrophy	Disease	MESH:D009133
38872258	886	894	fibrosis	Disease	MESH:D005355
38872258	974	977	H&E	Chemical	MESH:D006371
38872258	987	997	Sirius Red	Chemical	-
38872258	1142	1164	adenosine triphosphate	Chemical	MESH:D000255
38872258	1166	1169	ATP	Chemical	MESH:D000255
38872258	1175	1190	malondialdehyde	Chemical	MESH:D008315
38872258	1192	1195	MDA	Chemical	MESH:D008315
38872258	1278	1282	mice	Species	10090
38872258	1321	1335	muscle atrophy	Disease	MESH:D009133
38872258	1340	1348	fibrosis	Disease	MESH:D005355
38872258	1503	1506	ATP	Chemical	MESH:D000255
38872258	1629	1637	IL-1beta	Gene	16176
38872258	1653	1665	IkappaBalpha	Gene	18035
38872258	1682	1692	NF-kappaB.	Gene	18033
38872258	1734	1745	neuron loss	Disease	MESH:D009410
38872258	1770	1777	atrophy	Disease	MESH:D001284
38872258	1791	1794	ALS	Disease	MESH:D000690
38872258	1824	1829	SIRT1	Gene	93759
38872258	1830	1840	PGC-1alpha	Gene	19017
38872258	1913	1918	SIRT1	Gene	93759
38872258	1919	1927	IL-1beta	Gene	16176
38872258	1928	1937	NF-kappaB	Gene	18033
38872258	1990	2007	neuroinflammation	Disease	MESH:D000090862
38872258	2076	2079	ALS	Disease	MESH:D000690
38872258	Association	MESH:D000090862	18033
38872258	Association	MESH:D000690	93759
38872258	Association	18033	93759
38872258	Association	MESH:D000090862	16176
38872258	Association	MESH:D000090862	93759
38872258	Positive_Correlation	MESH:C071942	93759
38872258	Association	MESH:D000690	19017

